Best self-tanner for a streak-free glow declared ‘the best' now on sale for $10: Unreal Skin
While we're busy layering up to stay warm this cold season, an unexpected outfit change could suddenly have your arms and legs on show.
If you're ready to fake your way to a healthy glow, we've got just the deal for you.
Unreal Skin, home to the best-selling Self Tanning Cream, is currently marked down the hero formula to just $10 — yes you read that correctly.
Thanks to their moving sales, you can get your hands on the bottle shoppers rave about for the price of two coffees.
Easy to apply, streak-free and non-transferrable onto bed sheets, shoppers say it's the 'perfect product for a subtle tan that doesn't look orange and fake.'
All you have to do is enter the code MOVINGSALE at checkout to access this epic price.
Unreal Skin's Self-Tanning Cream is the perfect year round essential for a sun-safe glow, and now is the perfect time to stock up on a couple of tubes.
Usually retailing for $39.95, the best-seller is currently marked down to just $10 thanks to the brand's moving sale, and we're expecting hundreds to fly off the shelves.
Created by Perth-based entrepreneur Sarah Green, Unreal Skin launched into market over 12 months ago, and is already receiving incredible feedback for their hero product, with shoppers declaring it as 'the best'.
' The best thing about this tan is it doesn't smell - so you could just put it on like moisturizer during the day. You can eliminate all the marinating time - which is the worst part about tanning,' one shopper commented.
'Unreal Skin is amazing! It goes on smoothly, dries quickly, and delivers a natural, even tan. The colour is perfect—not orange at all,' another added.
'This is the first tan I have been able to use as a new Mum. The natural ingredients make it a huge win, plus it does not transfer onto bub leaving dreaded orange cheeks,' a third shopper wrote.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
2 hours ago
- ABC News
Australian doctor who volunteered in Gaza says hospital staff also starving
An anaesthetist at a public hospital in Perth says she decided to volunteer in Gaza after seeing images of the conflict in the media. "You just watch all these images on social media and television, and you just feel really helpless," Emma Giles said. After a 12-hour bus journey from Amman in Jordan, stopping at numerous checkpoints, Dr Giles arrived at Al-Quds Hospital in Gaza City in mid-May. She was only allowed to bring 3 kilograms of food with her and a limited amount of medical equipment for her four-week stay, where she lived at the hospital and worked with Palestinian medical staff. "There are fairly strict limits on what you can take with you," she told ABC Radio Perth's Jo Trilling. "You're allowed to take items which are for personal use only and for those that you can use in your own personal professional career. "So I couldn't take surgical stuff in, but I could take anaesthetic stuff in." Once at the hospital, Dr Giles got to work. "We had some anaesthetic machines which were quite similar to what I would use in Australia, but the disposable items weren't there," she said. "For example, [in Perth] I would put a breathing filter on my anaesthetic machine between every patient, so I don't transmit respiratory diseases, but we had none of those. Israel stopped allowing almost all food aid into Gaza on March 2. Dr Giles found the effect of severe food shortages was apparent in many of her patients by May. "We'd see a lot of people, particularly children, quite malnourished, poor healing," she said. "They would come back every two to three days to have further wash out of their really, really nasty wounds to try and prevent infection. "We'd just do it under anaesthesia." Dr Giles said the food shortages extended to the medical and nursing staff, who were only being given one meal a day by the hospital. "[The local staff] are absolutely exhausted and burnt out," she said. "They often work in multiple hospitals and do 24-hour shifts because travel is so difficult and dangerous. They choose to do longer shifts. Since she left, Dr Giles has been told the situation has worsened. "There is no food supplied by the hospital anymore," she said. "They're often starving and weak during the day, often feel a bit faint while they're working, and they're absolutely desperate to keep going." Dr Giles lost 6 kilograms during her four weeks in Gaza. On May 26, amid international outcry about the lack of food available, an organisation backed by the United States and Israel called the Gaza Humanitarian Foundation (GHF) began handing out food at distribution points. The Israeli military created long approach corridors for each of the GHF sites, and it soon became clear how dangerous they were. "The GHF started up close to where we were, about halfway through my time there, and that's when we started getting mass casualties as a real issue in the hospital," Dr Giles said. "They were open for maybe 10 to 15 minutes in a day, and then the people will just crowd in and get food. It's very much a survival of the fittest." The UN reported that as of July 21, 1,054 people had been killed in Gaza while trying to get food, 766 near GHF sites. "When they were crowding in [at GHF sites], often that would be seen as threatening by armed personnel around who would shoot them," Dr Giles said. "If we saw people walking past the hospital carrying bags of flour, we knew that there would be mass casualties coming in soon. "When you were operating on people, you often saw that the patients had this white ingrained flour in their hands — people who had actually managed to get food had then been wounded." Dr Giles travelled to Gaza as a volunteer with the Palestinian Australian New Zealand Medical Association (PANZMA).
AU Financial Review
6 hours ago
- AU Financial Review
Resmed beats forecasts as annual sleep device sales hit $8bn
Resmed has beaten full-year earnings and revenue forecasts on the back of strong global sales of its devices to treat sleep apnoea, shrugging off the threat of Donald Trump's trade tariffs and flagging a significant improvement in margins this year. California-based Resmed, which was founded in Sydney 35 years ago and is listed on the Nasdaq and the ASX, said net profit rose 37 per cent to $US1.4 billion ($2.2 billion) in the year to June 30, while revenue for the year increased 10 per cent to $US5.1 billion.
Sydney Morning Herald
a day ago
- Sydney Morning Herald
NeuroScientific locks in deal to scale-up stem cell production
Perth-based stem cell therapy pioneer NeuroScientific Biopharmaceuticals has started transferring its patented StemSmart process to one of Australia's biggest and most experienced cell therapy manufacturers to scale up clinical-grade production. Queensland-based Q-Gen Cell Therapeutics will take over the manufacturing of StemSmart's specific mesenchymal stromal stem cells (MSC) from Royal Perth Hospital's Cell and Tissue Centre. NeuroScientific says the technology transfer will allow it to establish MSC manufacturing for its StemSmart infusions for further clinical trials and pursue commercial opportunities. The MSC technology was developed as a last-line infusion treatment for critically ill patients, including those experiencing severe immune complications from bone marrow transplants, kidney and lung transplant rejection and inflammatory Crohn's disease. 'This relationship will allow the company to scale the manufacturing of its StemSmart technology.' NeuroScientific Biopharmaceuticals chief executive officer Nathan Smith NeuroScientific acquired the StemSmart technology in late June via its $4.1 million acquisition of unlisted Perth-based stem cell company Isopogen. Isopogen had previously signed a manufacturing contract with QIMR Berghofer, under which Q-Gen undertook manufacturing process development to scale up clinical-grade production of the StemSmart platform. Q-Gen, located in QIMR in Brisbane, has more than 25 years of experience in cell therapy manufacturing for industry. The laboratory specialises in manufacturing cellular immunotherapies for national and international clinical trials from 13 cleanrooms dedicated to cell manufacturing and quality control. NeuroScientific Biopharmaceuticals chief executive officer Nathan Smith said: 'We are very pleased to be partnering with Q-Gen given their extensive experience in manufacturing, process development and GMP production of biologic products for clinical trials. This relationship will allow the company to scale the manufacturing of its StemSmart technology to address substantial market opportunities.' StemSmart offers a step up from traditional MSC manufacturing in that the cells are grown in a special medium, becoming activated in the process. The platform technology was developed at Royal Perth Hospital and manufactured using the hospital's processes.
